SABBY AEZS 13G 12.17.15

Company

COSCIENS Biopharma Inc.

Filed

December 17, 2015

Accession Number

0001535610-15-000077

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →